FIELD: medicine, pharmacy.
SUBSTANCE: invention proposes a pharmaceutical composition comprising 4-(31-chloro-41-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline or its pharmaceutically acceptable salt (agent) and cellulose water-soluble ether, or cellulose water-soluble ester. The composition possesses the anti-proliferative effect. Cellulose ether and ester represented in the composition inhibit the precipitation rate of agent from solution in transport from stomach acid medium to upper regions of digestive tract medium with alkaline pH values that provides improved pharmacokinetic properties of the composition.
EFFECT: improved and valuable medicinal and pharmaceutical properties of composition.
23 cl, 4 dwg, 4 tbl, 14 ex
Authors
Dates
2008-03-10—Published
2003-02-24—Filed